,,ii #aafth ,,congress #b;d ,session ,s4 #cbbd ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,january #ba1 #bjbj,mr4 ,cassidy 7for himself and ,mr4 ,tester7 introduced the following bill2 which was read twice and referred to the ,committee on ,veterans' ,affairs ,a ,,bill ,to require the ,secretary of ,veterans ,affairs to allow for the use of commercial institutional review boards for research1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,,va ,research ,approval ,efficiency ,act of #bjbj4 #b4 ,use by ,department of ,veterans ,affairs of commercial institutional review boards in sponsored research trials 7a7 ,in general ,not later than #ij days after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall complete all necessary policy revisions within the directive of the ,veterans ,health ,administration numbered #abjj4je and titled ,requirements for the ,protection of ,human ,subjects in ,research1 to allow sponsored clinical research of the ,department of ,veterans ,affairs to use accredited commercial institutional review boards to review research proposal protocols of the ,department4 7b7 ,identification of review boards ,not later than #ij days after the completion of the policy revisions under subsection 7a71 the ,secretary shall-- 7#a7 identify accredited commercial institutional review boards for use in connection with sponsored clinical research of the ,department2 and 7#b7 establish a process to modify existing approvals in the event that a commercial institutional review board loses its accreditation during an ongoing clinical trial4 7c7 ,report 7#a7 ,in general ,not later than #ij days after the completion of the policy revisions under subsection 7a71 and annually thereafter1 the ,secretary shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on all approvals of institutional review boards1 including central institutional review boards and commercial institutional review boards4 7#b7 ,elements ,the report required by paragraph 7#a7 shall include1 at a minimum1 the following3 7,a7 ,the name of each clinical trial with respect to which the use of an institutional review board has been approved4 7,b7 ,the institutional review board or institutional review boards used in the approval process for each clinical trial4 7,c7 ,the amount of time between submission and approval4 #c4 ,creation of ,office of ,research ,reviews within the ,office of ,information and ,technology of the ,department of ,veterans ,affairs 7a7 ,in general ,not later than one year after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs shall establish within the ,office of ,information and ,technology of the ,department of ,veterans ,affairs an ,office of ,research ,reviews 7in this section referred to as the ,office74 7b7 ,elements ,the ,office shall do the following3 7#a7 ,perform centralized security reviews and complete security processes for approved research sponsored outside the ,department1 with a focus on multi-site clinical trials4 7#b7 ,develop and maintain a list of commercially available software preferred for use in sponsored clinical trials of the ,department and ensure such list is maintained as part of the official approved software products list of the ,department4 7#c7 ,develop benchmarks for appropriate timelines for security reviews conducted by the ,office4 7c7 ,report 7#a7 ,in general ,not later than one year after the establishment of the ,office1 the ,office shall submit to the ,committee on ,veterans' ,affairs of the ,senate and the ,committee on ,veterans' ,affairs of the ,house of ,representatives a report on the activity of the ,office4 7#b7 ,elements ,the report required by paragraph 7#a7 shall include the following3 7,a7 ,the number of security reviews completed4 7,b7 ,the number of personnel assigned for performing the functions described in subsection 7b74